Clomiphene citrate therapy has been found to improve the infertility rate in women suffering from polycystic ovarian disease (PCOD). However, there still exists a group of women with PCOD who fail to respond to clomiphene citrate or human menopausal gonadotropin/human chorionic gonadotropin or urofollitropin/chorionic gonadotropin treatment, an ovarian wedge resection by laparotomy approach which has been known for 50 years. Within the last decade, translaparoscopic electrocautery and laser drilling techniques have been utilized. In 1986, a translaparoscopic carbon dioxide laser ovarian wedge resection was introduced for resistant PCOD. This paper describes the surgical principle of a translaparoscopic carbon dioxide laser ovarian wedge resection. This type of treatment results in a 75% crude conception rate, with a 67% rate of healthy live birth. There was an 8% postsurgical adhesion rate among 12 cases that were incorporated into the study. This mode of therapy may prove to be very useful, safe, easy to perform, and cost effective as a second-line therapy for resistant PCOD in cases where medical inductions fail to achieve ovulation.
Ostrzenski, A. (1992). Endoscopic carbon dioxide laser ovarian wedge resection in resistant polycystic ovarian disease. International journal of fertility, 37(5), 295-299.
Ostrzenski A. Endoscopic carbon dioxide laser ovarian wedge resection in resistant polycystic ovarian disease. Int J Fertil. 1992;37(5):295-299.
Ostrzenski, Adam. "Endoscopic carbon dioxide laser ovarian wedge resection in resistant polycystic ovarian disease." International journal of fertility, vol. 37, no. 5, 1992, pp. 295-299.
A study was initiated to evaluate the prevalence of the luteinized unruptured follicle (LUF) syndrome in a group of 355 women with infertility. The diagnosis was established by carefully observing daily sonograms along with measuring estradiol, progesterone, and luteinizing hormone (LH) levels. Two distinct types of mature follicle LUF, in which release of an ovum was not demonstrated after a follicle attained maturity (serum estradiol reached 200 pg/mL while serum progesterone remained less than 2.5 ng/mL), versus premature luteinization LUF, where the serum progesterone increased above 2.5 ng/mL before follicular maturation was attained. The use of either hCG alone or hCG in combination with hMG in a single injection at the time of follicular maturation successfully corrected mature follicle LUF in 21 of 46 patients (46%), whereas ovulation-inducing drugs plus hCG or hCG and hMG corrected LUF in 24 of 25 patients (96%). Clomiphene citrate proved inferior to hMG in that it corrected LUF in 3 of 25 patients (12%) versus 12 of 22 patients (95%) who had undergone hMG therapy. Thus, hMG-hCG therapy is the most efficacious for mature follicle LUF, but because release can occur spontaneously on occasion by an appropriately timed single gonadotropin injection, one could offer the less costly options first. For premature luteinization, speeding up follicular maturation with gonadotropin therapy is effective. Upon failure of this technique, the more costly endogenous gonadotropin suppression followed by hMG can be employed.
The ability of solutions of carboxymethylcellulose (CMC) and 32% dextran 70 to reduce postoperative adhesion formation was examined using a rabbit uterine-horn scrape model. Utilization of 50 mL of 32% dextran 70 did not reduce adhesion formation compared with control rabbits. However, intraperitoneal instillation of CMC significantly reduced postoperative adhesion formation. An inverse correlation was established between either the concentration of CMC employed (1%, 2%, and 3%) or the volume of 2% CMC employed (20, 30, 40, and 50 mL) and the extent of adhesion formation. It is concluded that in this animal model CMC, but not 32% dextran 70, was able to retard postoperative adhesion formation.
A 12-month evaluation of the Ovulation Method of Natural Family Planning programme in Bangladesh is presented. Four hundred and forty-eight women entered the programme, 232 for spacing, 184 for limiting, and 32 to achieve pregnancy. Of the participating couples, 79% lived in rural areas and 20.3% were illiterate. The 416 who learned the ovulation method for avoiding pregnancy completed 2,358 months of use, with 14 unplanned pregnancies during the study period, which represents a pregnancy rate of 7.2 according to the Pearl Index. The discontinuation rate in the 12-month period was 2.4%.
In response to the lack of analyses of natural family planning (NFP) users in the UK a questionnaire was randomly distributed to teachers and users of this method in England and Wales in 1984-85. 464 of the 1000 questionnaires distributed were returned; the majority of respondents were married couples in the 25-34-year age group. Data on the demographic characteristics of these respondents countered the widely held belief that NFP users are predominantly Roman Catholics with large families. Only 59% of female respondents and 35% of male respondents were Catholic; moreover 65% had 2 pregnancies or fewer with an average number of 2.1. Specific NFP methods selected symptothermal (67%) Billings ovulation method (21%) calendar temperature (8%) and rhythm (3%). 52% reported previous oral contraceptive (OC) use. 260 respondents were using NFP only while 204 were combining NFP with the use of another method predominantly condoms. The primary sources friends (37%) the church (27%) and magazines/newspapers (17%); 74% were taught NFP by a trained instructor. The mean frequency of sexual intercourse per menstrual period--6.9 among exclusive NFP users and 7.9 among those who combined NFP with artificial methods--did not differ from that in the general population. 31% of female respondents and 20% of male respondents reported no problems with the requirement for abstinence during the fertile period; 78% said they had experienced no psychosexual problems as a result of NFP use. There were 179 unplanned pregnancies reported only 25 of which were method-related. An additional 34 pregnancies were regarded as resulting from inadequate training especially about NFP use post-OC postpartum and premenopausal.